贝宁与中国草药治疗COVID-19的比较研究
该研究在贝宁南部四个社区开展民族医学调查,确定最常用的六种草药,并用网络药理学比较其与中国用于COVID-19的三种药物和三种方剂的成分、靶点与通路。结果显示两者在抗炎和抗氧化应激方面有重叠,槲皮素和异欧前胡素对BEAS-2B细胞保护作用较强,分子对接显示六种成分与COVID-19相关靶点结合良好。
要点
- 贝宁最常用草药为Citrus aurantiifolia(13.18%)等六种,主要活性成分为槲皮素、山柰酚和β-谷甾醇。
- 贝宁与中国草药在炎症和氧化应激相关靶点及通路上存在重叠。
- Citrus aurantiifolia和Momordica charantia可能对轻症COVID-19有效,重症可加用Azadirachta indica。
核心结论
- 贝宁草药与中国草药在化合物、靶点和通路上有一定程度的重叠。
- Citrus aurantiifolia和Momordica charantia可能对轻症COVID-19有较好疗效,重症可在此基础上加用Azadirachta indica。
研究设计与样本
- 在贝宁南部四个社区(Cotonou、Abomey-Calavi、Zè、Ouidah)对草药商和传统治疗师开展民族医学调查。
- 采用网络药理学研究六种最常用草药的化学成分,并使用IPA等数据库和Cytoscape软件进行靶点与通路富集分析。
- 通过检测BEAS-2B细胞活力和炎症因子释放验证六种植物共同成分的功效,并用分子对接验证六种成分与COVID-19相关靶点的结合能力。
主要发现
- 最常用的六种草药为Citrus aurantiifolia(13.18%)、Momordica charantia(7.75%)、Ocimum gratissimum(7.36%)、Crateva adansonii(6.59%)、Azadirachta indica(5.81%)和Zanthoxylum zanthoxyloides(5.42%)。
- 主要植物科为Rutaceae、Lamiaceae、Cucurbitaceae、Meliaceae和Capparaceae。
- 网络药理学显示槲皮素、山柰酚和β-谷甾醇是贝宁草药的主要活性成分。
- 轻症COVID-19相关靶点来自C. aurantiifolia和M. charantia,重症相关靶点来自A. indica。
- 细胞活力和ELISA结果证实六种主要化合物可通过抑制炎症因子表达保护BEAS-2B细胞免受损伤,其中槲皮素和异欧前胡素更有效。
临床怎么用
- 贝宁最常用六种草药与中国用于COVID-19的三种药物和三种方剂在成分、靶点和通路上有重叠,可相互参考。
- Citrus aurantiifolia和Momordica charantia可能适用于轻症COVID-19,Azadirachta indica可能对重症有辅助价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: The worldwide use of natural remedies is an alternative therapeutic solution to strengthen immunity, fight, and prevent this disease. The rapid spread of the coronavirus disease worldwide has promoted the search for therapeutic solutions following different approaches. China and Benin have seen the use of natural remedies such as Chinese herbal medicine and local endemic plants as alternative solutions in treating COVID-19. AIM OF THE STUDY: The present study was designed to identify the prevalence of medicinal plant use in four municipalities of Benin most affected by COVID-19 and compare them with traditional Chinese medicine and finally verify the efficacy of the main components of the six plants most frequently used, via in vitro experiments. MATERIALS AND METHODS: This study targeting market herbalists and traditional healers was conducted in the form of an ethnomedicinal survey in four representative communities (Cotonou, Abomey-Calavi, Zè, and Ouidah) of southern Benin. The chemical compositions of the six most commonly used herbs were investigated using network pharmacology. Network-based global prediction of disease genes and drug, target, function, and pathway enrichment analysis of the top six herbs was conducted using databases including IPA and visualised using Cytoscape software. The natural botanical drugs involved three medicines and three formulas used in the treatment of COVID-19 in China from the published literature were compared with the top six botanical drugs used in Benin to identify similarities between them and guide the clinical medication in both countries. Finally, the efficacy of the common ingredients in six plants was verified by measuring the viability of BEAS-2B cells and the release of inflammatory factors after administration of different ingredients. Binding abilities of six components to COVID-19 related targets were verified by molecular docking. RESULTS: According to the medication survey investigation, the six most used herbs were Citrus aurantiifolia (13.18%), Momordica charantia (7.75%), Ocimum gratissimum (7.36%), Crateva adansonii (6.59%), Azadirachta indica (5.81%), and Zanthoxylum zanthoxyloides (5.42%). The most represented botanical families were Rutaceae, Lamiaceae, Cucurbitaceae, Meliaceae, and Capparaceae. The network pharmacology of these six herbal plants showed that the flavonoids quercetin, kaempferol, and β-sitosterol were the main active ingredients of the Benin herbal medicine. Chinese and Beninese herbal medicine are similar in that they have the same targets and pathways in inflammation and oxidative stress relief. Mild COVID-19-related targets come from C. aurantiifolia and M. charantia, and severe COVID-19-related targets come from A. indica A. Juss. Cell viability and enzyme-linked immunosorbent assay results confirmed that six major compounds could protect BEAS-2B cells against injury by inhibiting the expression of inflammatory factors, among which quercetin and isoimperatorin were more effective. Docking verified that the six compounds have good binding potential with COVID-19 related targets. CONCLUSIONS: These results suggest that Benin herbal medicine and Chinese herbal medicine overlap in compounds, targets, and pathways to a certain extent. Among the commonly used plants in Benin, C. aurantiifolia and M. charantia may have a good curative effect on the treatment of mild COVID-19, while for severe COVID-19, A. indica can be added on this basis.
引用
- Houeze EA, Wang Y, Zhou Q, et al. Comparison study of Beninese and Chinese herbal medicines in treating COVID-19. J Ethnopharmacol. 2023. PMID: 36773790. doi:10.1016/j.jep.2023.116172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。